Alice Blue - 20 years of trust
    • ANT APP
    • ANT WEB
    • 1LyAlgos
    • 1lyOptions
    • TradingView
    • MTF
    • Insurance
    • IPO
    • Stocks
    • Mutual Funds
  • Partner with us
  • Trade School
  • Pricing

    • Pricing

    About Us

    • About Us

    Calculator

    • Calculators
    • Brokerage Calculator
    • MTF Calculator

    Resources

    • Blog
    • Webinars
    • Videos (YouTube)

    Updates

    • News
    • Trading Holidays
    • Cares
    • Media Coverage
    • Disclosures

    Support

    • Support
    • Refer & Earn
    CommunityCareers
Login

    Start Investing in Stocks₹0 Account Opening

    +91
    Top Gainers Today52 Weeks High StocksHistorical Returns StocksShare Market TodayTop Losers TodayStocks Market NewsSagilityPC JewellerSuzlon EnergyVedanta PowerVedanta Oil and GasVodafone IdeaEquitas Sma. FinJain IrrigationYes BankMoneyviewOla ElectricReliance PowerTata Silver ETFVedanta Iron & SteelTata Gold ETFEternalJP Power Ven.Empower IndiaPine Labs
    NIFTY 50NIFTY Midcap 100NIFTY 100NIFTY RealtySENSEXNIFTY AutoNIFTY PSU BankNIFTY FMCGNIFTY BANKNIFTY MIDCAP 150BSE EnergyNIFTY PharmaBSE 100 LargeCap TMCNIFTY NEXT 50NIFTY MetalBSE 500 QUALITY 50
    Options Nifty 50Options BANK NIFTYOptions MIDCPNIFTYOptions FINNIFTYFutures Highest OIFutures OI GainersFutures OI LosersFutures Top Traded
    Debt Mutual FundsBest Debt Mutual fundsBest Equity Mutual fundsBest Hybrid Mutual fundsBest MidCap Mutual fundsBest Multicap Mutual fundsBest Large Cap Mutual fundsBest Small Cap Mutual fundsBest ELSS Mutual fundsBest Contra Mutual fundsBest Value Mutual fundsBest Arbitrage Mutual fundsBest Dividend Yield Mutual fundBest Aggressive Mutual fundsBest Conservative Mutual funds
    SIP CalculatorBrokerage CalculatorHome Loan EMI CalculatorLumpsum CalculatorMargin CalculatorFD CalculatorSWP CalculatorMF CalculatorEMI CalculatorStep-Up SIP CalculatorPPF Calculator
    What Is IPO?Open IPOsUpcoming IPOsHow to Apply for an IPOWhat is Grey Market Premium?
    Shares
    Top Gainers Today52 Weeks High StocksHistorical Returns StocksShare Market TodayTop Losers TodayStocks Market NewsSagilityPC JewellerSuzlon EnergyVedanta PowerVedanta Oil and GasVodafone IdeaEquitas Sma. FinJain IrrigationYes BankMoneyviewOla ElectricReliance PowerTata Silver ETFVedanta Iron & SteelTata Gold ETFEternalJP Power Ven.Empower IndiaPine Labs
    Indices
    NIFTY 50NIFTY Midcap 100NIFTY 100NIFTY RealtySENSEXNIFTY AutoNIFTY PSU BankNIFTY FMCGNIFTY BANKNIFTY MIDCAP 150BSE EnergyNIFTY PharmaBSE 100 LargeCap TMCNIFTY NEXT 50NIFTY MetalBSE 500 QUALITY 50
    F&O
    Options Nifty 50Options BANK NIFTYOptions MIDCPNIFTYOptions FINNIFTYFutures Highest OIFutures OI GainersFutures OI LosersFutures Top Traded
    Mutual Funds
    Debt Mutual FundsBest Debt Mutual fundsBest Equity Mutual fundsBest Hybrid Mutual fundsBest MidCap Mutual fundsBest Multicap Mutual fundsBest Large Cap Mutual fundsBest Small Cap Mutual fundsBest ELSS Mutual fundsBest Contra Mutual fundsBest Value Mutual fundsBest Arbitrage Mutual fundsBest Dividend Yield Mutual fundBest Aggressive Mutual fundsBest Conservative Mutual funds
    Calculators
    SIP CalculatorBrokerage CalculatorHome Loan EMI CalculatorLumpsum CalculatorMargin CalculatorFD CalculatorSWP CalculatorMF CalculatorEMI CalculatorStep-Up SIP CalculatorPPF Calculator
    IPO
    What Is IPO?Open IPOsUpcoming IPOsHow to Apply for an IPOWhat is Grey Market Premium?

    Company
    • About Us
    • Work with Us
    • Terms and Conditions
    • EKYC Guidelines
    • Contact Us
    • Cares
    Apps and Products
    • ANT APP
    • ANT WEB
    • 1LYOptions
    • Trade School
    • TradingView
    • 1LyAlgos
    Calculators
    • Calculators
    • SIP Calculator
    • Mutual Funds Return Calculator
    • Brokerage Calculator
    • RMS Live Updates
    • Term Coverage Calculator
    Important Links
    • Pricing
    • KYC Tracker
    • Market News
    • Global Indices
    • Gold Rate
    • Silver Rate
    • Trading Holidays

    Alice Blue
    3rd Floor, M.R.B.Arcade, No. 153/2,
    Bagalur Main Rd, Dwarka Nagar,
    Yelahanka, Bengaluru, Karnataka
    560063
    FacebookLinkedInX (Twitter)YouTubeInstagram

    ISO 27001:2022 Alice Blue is Certified Information Security Management System (ISMS)

    ISO 22301:2019 Alice Blue is Certified Business Continuity Management System (BCMS)

    DownloadsCircularsBank DetailsLearn
    Trade on TradingViewGet it on Google PlayDownload on the App Store

    Attention Investors!
    Prevent unauthorized transactions in your account update your mobile number/ email Id with your Stock Broker. Receive information of your transactions directly from Exchange on your mobile / email id at the end of the day.Prevent unauthorized transactions in your account update your mobile number/ email Id with your Stock Broker. Receive information of your transactions directly from Exchange on your mobile / email id at the end of the day.

    Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from the depository on your email id and/or mobile number to create a pledge. Pay 20% upfront margin of the transaction early to trade in the cash market segment. Investors may please refer to the Exchange’s Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020, and NSE/INSP/45534 dated August 31, 2020, and other guidelines issued from time to time in this regard. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

    Corporate Office: No. 153/2, 3rd Floor, M.R.B.Arcade, Bagalur Main Road, Dwaraka Nagar, Yelahanka, Bengaluru – 560 063, Karnataka.
    Registered Office: Old No.56/2 ,New No.58, LIC Nagar, Vinayagar Kovil Street, Erode -8,Tamil Nadu– 638002.
    Alice Blue Financial Services (P) Ltd : NSE EQ | NSE FO | NSE CDS-90112 SEBI REG : INZ000156038
    Alice Blue Financial Services (P) Ltd : BSE EQ | BSE FO | BSE CD-6670 SEBI REG : INZ000156038
    Alice Blue Financial Services (P) Ltd : CDSL DP ID 12085300 DP SEBI REG : IN-DP-364-2018
    Alice Blue Financial Services (P) Ltd : MCX-56710 SEBI REG : INZ000156038

    COMPLIANCE OFFICER: SARAVANAN R | Mobile No: +91 91872 10670 | Email:[email protected]

    We hereby declare that we are doing PRO trading

    Procedure to file a complaint on SEBI SCORES / SMART ODR : Register on SEBI SCORES 2.0 / SMART ODR. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances

    Click on the provided link to learn about the process for submitting a complaint on the ODR platform for resolving investor grievances. ODR Circular

    Investment in securities markets are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed SEBI prescribed limit.

    For queries regarding account opening or activation, email to accountactivation@aliceblueindia.com and for fund updates, email to funds@aliceblueindia.com

    Disclaimer: Attention investors:1) Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors. 2) Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. 3) Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. 4) For demat and trading account closure with AliceBlue, kindly visit https://aliceblueonline.com/support/closure-freezing-reactivation or “ANT APPLICATION” under your profile and click on Settings -> Account Closure section -> Initiate account closure.

    No need to issue cheques by investors while subscribing to an IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in the investor’s account.

    Investors are requested to note that Alice Blue Financial Services Private Limited is permitted to receive money from investor through designated bank accounts only named as Up streaming Client Nodal Bank Account (USCNBA). Alice Blue Financial Services Private Limited is also required to disclose these USCNB accounts to Stock Exchange. Hence, you are requested to use following USCNB accounts only for the purpose of dealings in your trading account with us. The details of these USCNB accounts are also displayed by Stock Exchanges on their website under “Know/ Locate your Stock Broker. Bank Details (Valid UPI FAQ).

    DND PolicyInvestor CharterLegal DocumentationPrivacy policyFeedbackAnnual ReturnsAdvisory for InvestorsE-votingMandatory Member Details

    Performance

    Historical price movement and trading activity

    Trading Data

    Today's High

    2528

    Today's Low

    2467.4

    Open

    2469.3

    Previous Close

    2492.8

    Volume

    681497

    Total Traded Value High

    1705506360.9

    Technicals

    Price-based indicators and levels

    Indicators

    IndicatorValueSignal
    Relative Strength Index (RSI)+58.49Neutral
    MACD+9.30Bullish

    Support and Resistance Levels

    R32551.20
    R22530.10
    R12499.70
    S12448.20
    S22427.10
    S32396.70

    Moving Averages

    PeriodSMAEMA
    20D Moving Average2389.312392.53
    50D Moving Average2382.532396.22
    200D Moving Average2312.852371.64
    Mankind Pharma Ltd

    Mankind Pharma Ltd

    NSE: MANKIND | BSE: 543904
    ₹2492.8+23.50 (0.95%)
    BuySell

    News

    Mankind Pharma's credit ratings reaffirmed by CRISIL, including Rs 2,500 crore in debentures

    29 Oct 2026

    Mankind Pharma Ltd announced today, October 29, 2026, that CRISIL Ratings Limited (“CRISIL”) has reaffirmed and withdrawn credit ratings for several of the company’s instruments, as per Regulation 30 & 51 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Specifically, CRISIL reaffirmed the rating of “Crisil AA+/Stable” for Non-Convertible Debentures amounting to Rs 400 crore and another tranche of Non-Convertible Debentures amounting to Rs 2,100 crore, while withdrawing the “Crisil AA+/Stable” rating previously assigned to Non-Convertible Debentures totaling Rs 2,500 crore; additionally, CRISIL has withdrawn the “Crisil A1+” rating for Commercial Paper valued at Rs 1,500 crore, with the detailed rationale accessible via a link provided in the release and also on the company’s website at www.mankindpharma.com.

    Mankind Pharma Ltd rises for third straight session

    21 Sept 2026

    Mankind Pharma Ltd is quoting at Rs 2439, up 6.01% on the day as on 12:49 IST on the NSE. The stock is down 6.01% in last one year as compared to a 7.1% slide in NIFTY and a 20.91% slide in the Nifty Pharma index.

    Mankind Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 2439, up 6.01% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.29% on the day, quoting at 23413.6. The Sensex is at 74818.76, up 0.71%. Mankind Pharma Ltd has gained around 2.72% in last one month. Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has gained around 2.67% in last one month and is currently quoting at 26710.1, up 1.25% on the day. The volume in the stock stood at 10.39 lakh shares today, compared to the daily average of 3.26 lakh shares in last one month. The benchmark September futures contract for the stock is quoting at Rs 2443, up 5.42% on the day. Mankind Pharma Ltd is down 6.01% in last one year as compared to a 7.1% slide in NIFTY and a 20.91% slide in the Nifty Pharma index. The PE of the stock is 42.34 based on TTM earnings ending June 26.

    Mankind Pharma Ltd slips for fifth straight session

    9 Sept 2026

    Mankind Pharma Ltd is quoting at Rs 2280.2, down 1.25% on the day as on 13:19 IST on the NSE. The stock tumbled 12.59% in last one year as compared to a 5.73% slide in NIFTY and a 20.8% spurt in the Nifty Pharma index.

    Mankind Pharma Ltd is down for a fifth straight session today. The stock is quoting at Rs 2280.2, down 1.25% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.4% on the day, quoting at 23541.1. The Sensex is at 75160.39, down 0.55%.Mankind Pharma Ltd has lost around 6.47% in last one month.Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has increased around 0.92% in last one month and is currently quoting at 26880.8, down 0.59% on the day. The volume in the stock stood at 1.21 lakh shares today, compared to the daily average of 3.25 lakh shares in last one month. The benchmark September futures contract for the stock is quoting at Rs 2290.3, down 0.87% on the day. Mankind Pharma Ltd tumbled 12.59% in last one year as compared to a 5.73% slide in NIFTY and a 20.8% spurt in the Nifty Pharma index. The PE of the stock is 42.12 based on TTM earnings ending June 26.

    Mankind Pharma Ltd eases for fifth straight session

    27 May 2026

    Mankind Pharma Ltd is quoting at Rs 2412.2, down 0.47% on the day as on 13:19 IST on the NSE. The stock tumbled 2.88% in last one year as compared to a 3.49% slide in NIFTY and a 15.46% spurt in the Nifty Pharma index.

    Mankind Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2412.2, down 0.47% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.11% on the day, quoting at 23888.4. The Sensex is at 75882.34, down 0.17%.Mankind Pharma Ltd has gained around 6.53% in last one month.Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has increased around 6.66% in last one month and is currently quoting at 24659.2, up 0.16% on the day. The volume in the stock stood at 3.04 lakh shares today, compared to the daily average of 7.96 lakh shares in last one month. The benchmark June futures contract for the stock is quoting at Rs 2429.3, down 0.46% on the day. Mankind Pharma Ltd tumbled 2.88% in last one year as compared to a 3.49% slide in NIFTY and a 15.46% spurt in the Nifty Pharma index. The PE of the stock is 47.06 based on TTM earnings ending March 26. Powered by Capital Market - Live News

    Mankind Pharma Ltd rises for third straight session

    15 May 2026

    Mankind Pharma Ltd is quoting at Rs 2511.4, up 2% on the day as on 12:49 IST on the NSE. The stock is down 2.38% in last one year as compared to a 4.94% slide in NIFTY and a 13.93% slide in the Nifty Pharma index.

    Mankind Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 2511.4, up 2% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.4% on the day, quoting at 23783.6. The Sensex is at 75701.49, up 0.4%. Mankind Pharma Ltd has gained around 19.34% in last one month. Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has gained around 9.71% in last one month and is currently quoting at 24551.05, up 0.39% on the day. The volume in the stock stood at 7.22 lakh shares today, compared to the daily average of 5.15 lakh shares in last one month. The benchmark May futures contract for the stock is quoting at Rs 2486.3, up 1.66% on the day. Mankind Pharma Ltd is down 2.38% in last one year as compared to a 4.94% slide in NIFTY and a 13.93% slide in the Nifty Pharma index. The PE of the stock is 57.52 based on TTM earnings ending December 25. Powered by Capital Market - Live News

    Showing 1–5 of 7

    Insider Activity

    Puja JunejaPromoter Group
    Disposed
    2271336
    Shares Worth
    ₹4,78,64,99,920
    Reported On9 Feb 2024
    ModeBlock Deal
    Arjun JunejaPromoter Group
    Disposed
    2401128
    Shares Worth
    ₹5,06,00,17,091
    Reported On9 Feb 2024
    ModeBlock Deal
    Sheetal AroraPromoter
    Disposed
    1817070
    Shares Worth
    ₹3,82,92,02,465
    Reported On9 Feb 2024
    ModeBlock Deal
    Trade now

    Overview

    Pharmaceuticals - Indian - Bulk Drugs & Formln LrgNSE / BSE

    Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company with the name 'Mankind Pharma Private Limited', by the Registrar of Companies, Delhi and Haryana, at New Delhi. Pursuant to conversion of Company to a Public Limited dated July 14, 2005, name of the Company was changed to 'Mankind Pharma Limited' and the RoC issued a fresh Certificate of Incorporation on April 13, 2006. The Company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and chronic therapeutic areas across, as well as several consumer healthcare products. It is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins /minerals / nutrients and respiratory. In 2004, the Company entered the chronic pharmaceutical segment with the launch of Amlokind' tablets and Glimestar' tablets amongst others. It set up their first manufacturing facility at Paonta Sahib, in Himachal Pradesh during year 2005. It entered the ophthalmic pharmaceutical segment with the launching of Lubistar Eye Drops' and Tobastar Eye Drops'. In 2007, the Company diversified into the consumer healthcare segment with the launch of Manforce' brand and have since established several differentiated brands in condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations categories. It entered into the business of animal healthcare segment and launched Bandykind' and Ceftiforce'. It established their Unit II manufacturing facility at Paonta Sahib, Himachal Pradesh in year 2009. It launched the brand, Preganews' into the consumer healthcare segment in year, 2010. In 2012, it set up their first R&D centre at IMT Manesar, in Haryana. Thereafter, in year 2014, the Company acquired Shree Jee Laboratory Private Limited along with its API manufacturing site at Behror, Rajasthan. It set up the Unit II manufacturing facility at Paonta Sahib, Himachal Pradesh. In 2015, subsidiaries like Lifestar Pharma LLC in the US and Mankind Pharma Pte. Limited in Singapore were formed into with the Company. In 2017, a new manufacturing facility got established in Sikkim. In 2019, the Company entered into female infertility business segment and launched Dydroboon' tablets. In 2020, a subsidiary, Lifestar Pharmaceuticals Private Limited was formed in Nepal. The Company introduced a specialty therapeutic division for cardiovascular diseases (CVD) drugs segment and launched Cilaheart' tablets and Statpure' tablets in the market. It launched Zukanorm' tablets for diabetes pharmaceuticals segment. Another new subsidiary, Mankind Pharma FZ-LLC in Dubai, UAE got incorporated during the year 2021. It launched Mlife' tablets in the specialty division for therapeutic respiratory pharmaceuticals. It entered into specialty therapeutic neuro/central nervous system pharmaceuticals segment business with the launch of Trugaba-NT' tablets and Prebris-MNT' tablets. In 2022, the Company acquired formulations brands in India and Nepal from Panacea Biotec Pharma Limited and Panacea Biotec Limited. Further, it entered into the transplant segment with the launch of Pangraf Capsules' and Mycept' tablets. It entered into the business of oncology segment with the launch of injection Pacliall'. It acquired Daffy' and Combihale' brands from Dr. Reddy's Laboratories. In April 2023, Company made an Initial Public Offer of 40,058,844 Equity Shares by raising funds aggregating to Rs 4326.35 Crore through Offer for Sale. During the FY 2022-23, the Company acquired 90% shareholding of Upakarma Ayurveda Private Limited, pursuant to which Upakarma Ayurveda became a step down subsidiary of the Company. Further, it also acquired 100% shareholding of Mankind Agritech Private Limited, making Mankind Agritech a wholly owned subsidiary of the Company. The Company also acquired minority stake of 6.30% in Actimed Therapeutics Limited. The erstwhile wholly owned subsidiaries, Lifestar Pharma Private Limited and Magnet Labs Private Limited got amalgamated with the Company and the Scheme of Amalgamation became effective from March 30, 2023. During the FY 2023-24, Mankind Medicare Private Limited was incorporated as the wholly owned subsidiary of the Company. The Company sold the Over the Counter (OTC) business of the Company to Mankind Consumer Products Private Limited, Wholly Owned Subsidiary Company as a going concern via slump sale on April 2, 2024. On October 23, 2024, Company acquired a 100% stake in Bharat Serums and Vaccines Limited (BSV), making it a wholly owned subsidiary of the Company. Urology Specialty Division launched in FY 2025. The Company acquired Rivotril brand from Roche, strengthening the CNS therapy in FY 2026.

    Fundamentals

    Financial strength and ownership structure

    Valuation & Ratios

    Market Capitalisation

    ₹82,807.17

    Price to Book (PB)

    0.12

    Price to Earnings (PE)

    1.05

    Return on Equity (ROE)

    12.65%

    Earnings Per Share (EPS)

    1,938.23

    Dividend Yield

    0.05%

    Financial Performance

    2606.95
    2422.24
    2867.85
    3061.43
    3198.79
    3079.37
    3570.35
    3697.16
    3567.20
    3442.93
    4030.59
    4337.86
    Dec
    '23
    Mar
    '24
    Jun
    '24
    Sep
    '24
    Dec
    '24
    Mar
    '25
    Jun
    '25
    Sep
    '25
    Dec
    '25
    Mar
    '26
    Jun
    '26
    Sep
    '26

    Shareholding Pattern

    72.66%
    72.66%
    72.63%
    72.62%
    Dec
    '25
    Mar
    '26
    Jun
    '26
    Sep
    '26